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© 2011 The Japan Society of Histochemistry and Cy- The “in vivo cryotechnique” (IVCT) is a powerful tool to directly freeze living animal organs
in order to maintain biological components in frozen tissues, reflecting their native states. In
this study, mesenteric lymph nodes of living mice were directly frozen with IVCT, and we did
morphological studies and immunohistochemical analyses on a hyaluronic acid receptor,
LYVE-1. In lymph nodes, widely open lymphatic sinuses were observed, and many lympho-
cytes adhered to inner endothelial cells along subcapsular sinuses. The LYVE-1 was clearly
immunolocalized at inner endothelial cells of subcapsular sinuses, as well as those of
medullary sinuses. Conventional pre-embedding electron microscopy also showed LYVE-1
immunolocalization along both the apical and basal sides of cell membranes of inner endo-
thelial cells. By triple-immunostaining for LYVE-1, smooth muscle actin, and type IV colla-
gen, the LYVE-1 was immunolocalized only in the inner endothelial cells, but not in outer
ones which were surrounded by collagen matrix and smooth muscle cells. Thus, the func-
tional morphology of lymph nodes in vivo was demonstrated and LYVE-1 immunolocalization
in inner endothelial cells of subcapsular sinuses suggests hyaluronic acid incorporation into
lymph node parenchyma.
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I. Introduction
Lymph nodes are peripheral lymphatic organs con-
necting afferent lymphatic vessels to efferent ones via
subcapsular, intermediate, and medullary sinuses. Some
markers specific for lymphatic vessels are lymphatic vessel
endothelial hyaluronan receptor-1 (LYVE-1) [2, 25], vascu-
lar endothelial growth factor receptor-3 (VEGFR-3) [13],
prox1 [26, 46], and podoplanin [3, 45]. LYVE-1 is a 322-
amino acid transmembranous glycoprotein homologous to
an inflammatory leukocyte homing receptor, CD44, and
both of them are receptors for hyaluronic acid [8, 9, 29]. In
lymphatic sinuses of rat lymph nodes, LYVE-1 was reported
to be localized in endothelial and reticular cells of medullary
sinuses [25]. Recently, it was also reported that a type of
macrophage expressed LYVE-1 in some lymphatic vessels
[28]. Therefore, it is of interest to examine the LYVE-1
immunolocalization in lymph nodes because they have
specific lymph sinuses surrounded by endothelial cells
which connect to the lymphatic vessels.
To clarify the morphological states of functioning
animal organs, we have already proposed that the “in vivo
cryotechnique” (IVCT) is a powerful tool by which living
animal organs are directly frozen in vivo [23, 38]. IVCT can
prevent morphological artifacts of cells and tissues caused
by tissue-resection and immersion- or perfusion-fixation [1,
21, 31]. It is also possible to examine immuolocalization
of soluble proteins, as well as small amino acids, with highBai et al. 82
immunoreactivity, reflecting their original localization [15,
21, 34, 39, 48]. In this study, we performed morphofunctional
analyses of mouse mesenteric lymph nodes under normal
blood circulation prepared with IVCT, and examined
immunolocalization in situ of LYVE-1, type IV collagen
and smooth muscle actin in the lymph nodes.
II. Materials and Methods
Tissue preparation using the “in vivo crotechnique” (IVCT) 
or conventional methods
All animal experiments were performed in accordance
with guidelines by the Animal Care and Use Committee,
University of Yamanashi. A total of 15 adult C57BL/6J
male mice, weighing 20–30 g, were prepared by the follow-
ing different methods. (i) In vivo cryotechnique (IVCT)
(Fig. 1): Under pentobarbital anesthesia, abdominal cavities
of 9 mice were opened and mesenteric lymph nodes were
carefully exposed (Fig. 1a). Isopentane-propane cryogen
(−193°C) cooled in liquid nitrogen was directly poured
over mesenteric lymph nodes (Fig. 1b) while their hearts
were beating, in a similar way to that for living mouse
livers [21]. Then, the frozen lymph nodes were removed
with a dental electric drill in liquid nitrogen (Fig. 1c),
and processed for freeze-substitution (FS) fixation. Briefly,
the frozen specimens were freeze-substituted in acetone
containing 2% paraformaldehyde (PFA) at −80°C in dry
ice-acetone for 48 hr, and gradually warmed up to room
temperature (RT). (ii) Immersion-fixation and alcohol-
dehydration (IM-DH): Mesenteric lymph nodes of 3 mice
were surgically resected and immersed into 2% PFA in
0.1 M phosphate-buffer solution (PB; pH 7.4) for 2 hr at
RT. (iii) Perfusion-fixation and alcohol-dehydration (PF-
DH): Three mice were transcardially perfused with 2% PFA
in 0.1 M PB, and their mesenteric lymph nodes were
resected and additionally immersed in the same fixative for
2 hr. The specimens prepared by the latter two methods, (ii)
and (iii), were processed for common alcohol-dehydration.
Fixed lymph nodes were routinely embedded in either
paraffin wax or 30% sucrose for cryosections, as described
previously [18, 37].
Immunostaining for light microscopy
Paraffin sections (2–4 μm thick) or cryosections (6
μm thick) were cut, and attached to Matsunami Adhesive
Slide (MAS)-coated glass slides (Matsunami Glass, Osaka,
Japan). Some deparaffinized sections were stained with
hematoxylin-eosin (HE) to obtain morphological findings.
The other deparaffinized sections or cryosections were
rehydrated in phosphate-buffered saline (PBS) and immuno-
stained with various antibodies, as previously described
[22]. Briefly, all serial sections for the immunoperoxidase
staining were first blocked with 1% hydrogen peroxide in
PBS, and incubated in a blocking solution, PBS containing
5% normal goat serum (NGS) (Vector Laboratories; Burlin-
game, CA, USA) for 1 hr. They were immunostained with
rabbit polyclonal anti-LYVE-1 (Abcam; Cambridge, UK) in
PBS containing 5% NGS at 4°C overnight. The immuno-
stained sections were then incubated in biotin-conjugated
goat anti-rabbit IgG (Vector Lab.) at RT for 1 hr. The
immunoreaction products were visualized with Vectastain®
avidin-biotin complex (ABC) reagent (Vector Lab.) and a
metal-enhanced  diaminobenzidine  (DAB)  substrate  kit
(Pierce; Rockford, IL, USA), and additionally fixed with
0.04% osmium tetroxide (OSO4) solution, as described
before [21]. All immunostained paraffin sections were
counterstained with methylgreen, embedded in glycerol,
and observed in a light microscope (BX-61; Olympus,
Tokyo, Japan).
For triple-immunostaining for LYVE-1, type IV col-
lagen and smooth muscle actin, some cryosections were
blocked with 5% gelatin in PBS for 1 hr, and immunostained
with a rat monoclonal anti-type IV collagen α2-chain (H22)
antibody [30] at 4°C overnight. After washing in PBS, they
were incubated with a biotinylated donkey anti-rat IgG anti-
body (Jackson Immunoresearch Laboratories; West Grove,
PA, USA), a rabbit polyclonal anti-LYVE-1 antibody and a
mouse anti-smooth muscle actin antibody (Thermo Fisher
Scientific; Fremont, CA, USA) at RT for 1 hr. Next, they
were incubated with Alexa Fluor 546-conjugated streptavi-
din, an Alexa Fluor 488-conjugated donkey anti-rabbit IgG
antibody and an Alexa Fluor 633-conjugated goat anti-
mouse IgG antibody (Invitrogen; Carlsbad, CA, USA) at RT
for 1 hr. The immunostained sections were mounted with
Vectashield (Vector Lab.), and observed under a confocal
laser scanning microscope (FV 1000: Olympus; Tokyo,
Japan).
Pre-embedding immunostaining for electron microscopy
Some parts of lymph node specimens prepared by
perfusion-fixation were infiltrated in PBS containing 30%
sucrose [44], and 6 μm cryosections were cut. They were
Fig. 1. Schematic representation of the “in vivo cryotechnique”
(IVCT) for mouse mesenteric lymph nodes. Under anesthesia,
mesenteric lymph nodes were exposed (a), and isopentane-propane
cryogen (−193°C) was directly poured over them (b). Then, the
frozen lymph nodes were taken out with a dental electric drill in
liquid nitrogen (c), and processed for freeze-substitution (FS)
fixation.Lymph Nodes with In Vivo Cryotechnique 83
immunostained for LYVE-1 with the common immuno-
peroxidase-DAB method as reported before [40, 41]. They
were routinely embedded in epoxy resin by the inverted
gelatin capsule method, and ultrathin sections were cut with
an ultramicrotome. They were briefly stained with uranyl
acetate alone and observed in a transmission electron
microscope (H-7500: Hitachi; Tokyo, Japan).
III. Results
Histological findings of lymph node tissues
First, we obtained some histological findings with
hematoxylin-eosin (HE) staining of mesenteric lymph nodes
prepared by IVCT-FS (Fig. 2a–d). In the previous study,
the tissue areas with hardly visible ice crystals were approx-
imately 200–300 μm, depending on the distance of the
tissues from the organ surface [22]. In the present study,
the areas marked with dotted lines were showing better
morphology without tissue damage (Fig. 2b). Their surface
structures were thin layers of dense connective tissues which
form obvious capsules of lymph nodes (Cp in Fig. 2a–c).
The capsules contained several afferent lymphatic vessels
(ALV in Fig. 2a). Parenchyma of lymph nodes was divided
into two common zones: a cortex (Co in Fig. 2a, b) and
medulla (Me in Fig. 2a). The cortex consisted of an outer
cortex (OC in Fig. 2a) with numerous lymphatic nodules
(LyN in Fig. 2a) and an inner cortex (IC in Fig. 2a) with
lymphocyte accumulation extending into the medulla (Me in
Fig. 2a). Between the capsule of dense connective tissues
and parenchyma, widely open subcapsular sinuses (SS in
Fig. 2a, b) were observed with IVCT-FS, connecting to
medullary sinuses (MeS in Fig. 2a, d) through intermediate
sinuses (IS in Fig. 2a, c). Stripy appearance seen in the deep
sinuses was because of freezing lymph fluid alone (Fig. 2c,
d), as compared to the surface sinus (Fig. 2b). Many small
lymphocytes with chromatin-condensed nuclei were local-
ized in the lymphatic sinuses. Some lymphocytes adhered to
inner endothelial cells along subcapsular sinuses (arrow-
heads in Fig. 2b). Thus, naturally open spaces of lymphatic
sinuses and the in situ location of flowing lymphocytes were
well retained with IVCT, probably showing their original
living states.
Fig. 2. Light micrographs of hematoxylin-eosin (HE) staining for paraffin sections of mesenteric lymph nodes prepared by IVCT followed by
FS fixation. (a) Lower magnified view of a lymph node showing wide areas from the cortex (Co) to medulla (Me). In the cortex, outer (OC) and
inner (IC) cortices are observed. Cp, capsule; ALV, afferent lymphatic vessel; IS, intermediate sinus; LyN, lymphatic nodule; SS, subcapsular
sinus. The deep areas of dotted lines in this lymph node are showing tissue damage caused by ice crystal formation (b). The panels (b), (c) and
(d) are higher magnified views of three parts shown as rectangles in (a). (b) Space of subcapsular sinus (SS) is opening, and the outside is
surrounded by a capsule (Cp). Small lymphocytes with dense chromatin in nuclei are localized along inner endothelial cells of SS (arrowheads
in b). (c) An intermediate sinus (IS) is connecting from SS. (d) Medullary cords (MeC) and open medullary sinuses (MeS) are clearly observed
in the medulla of lymph nodes in vivo. Lymphocytes are observed in intermediate and medullary sinuses (arrowheads in c, d). Bars=100 μm (a),
50 μm (b–d).Bai et al. 84
Immunolocalization of LYVE-1 in lymphatic sinuses
With IVCT-FS, it was easy to determine the immuno-
localization of LYVE-1, because spaces of lymphatic
sinuses were well maintained (Fig. 3), generally reflecting
their living states. The LYVE-1 was immunolocalized
along the inner side of subcapsular sinuses (arrows in Fig.
3d, e), showing inner endothelial cells and reticular cells.
Along the outer side of subcapsular sinuses, LYVE-1 was
immunolocalized in some cells among connective tissues
of capsules (red arrowhead in Fig. 3d), but not in endothelial
cells (green arrowhead in Fig. 3d, e), which might be a
type of macrophage [5, 32]. In medullary sinuses, LYVE-
1 was immunolocalized in endothelial and reticular cells
(Fig. 3f). These findings indicate that the expression and
localization of LYVE-1 are different among endothelial
cells of the subcapsular sinuses.
LYVE-1 immunolocalization in afferent lymphatic vessels, 
subcapsular sinuses and intermediate sinuses
Next, the LYVE-1 immunolocalization was examined
Fig. 3. Serial paraffin sections of a mesenteric lymph node prepared by IVCT-FS method stained with hemtoxylin-eosin (HE) (a), immuno-
stained for LYVE-1 (b) or immunocontrol without the primary anti-LYVE-1 antibody (c). Panels (d), (e) and (f) show higher magnified views
of three parts shown as rectangles in (b). Inset in (e) is highly magnified view of inner endothelia cells shown by the square. The LYVE-1 is
immunolocalized in both luminal and basal cell membranes of inner endothelial cells (arrows in d, e), but not in outer endothelial cells (green
arrowheads in d, e) of the subcapsular sinus (SS). LYVE-1 immunopositive cells in capsules (red arrowhead in d) are apparently different
from the endothelium. In medullary sinuses (MeS in f), LYVE-1 (arrows in f) is immunolocalized in endothelial and reticular cells. Co, Cortex;
Cp, Capsule; Me, Medulla; MeC, Medullary cord. Bars=100 μm (a–c), 50 μm (d–f), 10 μm (inset of e).Lymph Nodes with In Vivo Cryotechnique 85
from afferent lymphatic vessels into the mesenteric lymph
nodes (Fig. 4). Along the afferent lymphatic vessel (ALV in
Fig. 4), LYVE-1-immunopositive cells were observed in
connective tissues of capsules (red arrowheads, Fig. 4d),
but not in endothelial cells of ALV (blue arrowheads,
Fig. 4d). Outer endothelial cells were LYVE-1-immuno-
negative along the subcapsular sinuses and intermediate
sinuses, but LYVE-1 immunolocalization was seen at cell
membranes of the inner endothelial cells (Fig. 4e, inset) and
reticular cells, as described in the previous section. Thus, it
was confirmed that the inner endothelial cells of subcapsular
sinuses are initial portions for the appearance of LYVE-1 in
lymph nodes. LYVE-1 immunolocalization at high endo-
thelial venules (HEVs) was similar to that in the previous
studies (Fig. 4f) [27].
LYVE-1 immunoreactivity of lymph nodes with various 
preparation methods
The LYVE-1 immunoreactivity was compared among
various preparation methods (Fig. 5), because the cryotech-
niques such as IVCT and quick-freezing of fresh tissues
(FQF) are better approaches to obtain strong immuno-
reactivity against some antibodies [19, 20], but translocation
of soluble proteins was easily induced by ischemia, anoxia,
and mechanical stress of resected tissues with FQF [1, 15].
The LYVE-1 immunoreactivity was stronger in tissues
with IVCT-FS (Fig. 5a–c), compared to the conventional
chemical fixation followed by alcohol-dehydration (Fig. 5d–
i). By different antibody dilutions of 1:300 and 1:7500, the
LYVE-1 immunoreactivity was clearly observed along cell
membranes and basal sides of the inner endothelial cells,
reticular cells or in some cells of the capsule (Fig. 5b, c).
In addition, the immunolocalizations of LYVE-1 are inter-
rupted in the inner endothelial cells (inset of Fig. 5c), as
reported before [28]. Therefore, it was beneficial to use a
lymphatic vessel marker, LYVE-1, in the IVCT-FS samples
of lymph nodes to reflect the native states of subcapsular
and intermediate sinuses.
Immunoelectron microscopy of LYVE-1 in lymph nodes
To determine more precise immunolocalization of
LYVE-1 in endothelial cells along subcapsular sinuses, pre-
embedding immunoelectron microscopy was performed for
the perfusion-fixed mouse mesenteric lymph nodes (Fig. 5j,
k). Immunoreaction products were observed to be along cell
membranes of inner endothelial cells in subcapsular sinuses
(black arrows, Fig. 5j, k). They were localized not only at
the apical sides, but also the basal sides of the endothelial
cells, as reported before [30]. In addition, the immunolocal-
ization of LYVE-1 was strongly observed at the luminal
Fig. 4. Serial paraffin sections of a mesenteric lymph node prepared by IVCT-FS method, stained with hemtoxylin-eosin (HE; a), and immuno-
stained for LYVE-1 (b, d, e, f) or immunocontrol without the primary anti-LYVE-1 antibody (c). The figure (d–f) shows higher magnified
views of the parts shown as rectangles in (b). Inset in (e) is a highly magnified view of inner endothelial cells shown by the square. The LYVE-
1 is not immunolocalized in endothelial cells of an afferent lymphatic vessel (ALV; blue arrowheads in d). In the subcapsular sinus (SS in d, e)
facing the ALV and intermediate sinus (IS, e), LYVE-1-immunopositive cells are observed in the capsular stroma (red arrowheads in d, e) and
reticular cells (black arrows in e) or both luminal and cell membranes of inner endothelial cells (black arrows in d–f), but not in outer endo-
thelial cells (green arrowheads in d, e). The LYVE-1 is also immunolocalized in endothelial cells of high endothelial venules (HEVs in f).
Co, Cortex; Cp, Capsule; LyN, Lymphatic nodule. Bars=50 μm (a–d), 10 μm (inset of e).Bai et al. 86
Fig. 5. Hematoxylin-eosin (HE) staining (a, d, g) and LYVE-1 immunostaining with different concentrations of primary anti-LYVE-1 antibody
(1:300 in b, e, h and 1:7500 in c, f, i) in serial paraffin sections prepared by IVCT-FS (a–c), immersion-fixation followed by alcohol-dehydra-
tion (IM-DH; d–f) or perfusion-fixation followed by alcohol-dehydration (PF-DH; g–i). Insets in (b) and (c) are highly magnified views of inner
endothelial cells shown by the squares. With IVCT-FS, a row of lymphocytes along subcapsular sinus (SS) is observed in this area (arrowhead
in a), compared to IM-DH or PF-DH (arrowheads in d, g). The LYVE-1 immunoreactivity is more clearly detected at a 1:7500 primary
antibody dilution in samples with IVCT-FS (c), but it is decreased in samples with IM-DH (f) or PF-DH (i). (j) and (k) Pre-embedding immuno-
electron microscopy for LYVE-1 in a mesenteric lymph node. The LYVE-1 is immunolocalized at both luminal and basal cell membrane
surfaces of inner endothelial cells (IE; black arrows) along subcapsular sinus (SS), but not in outer endothelial cells (OE; white arrowheads).
The LYVE-1 is also immunolocalized in some cells in the interstitium of capsules (Cp) surrounding SS (white arrow). Co, Cortex; Cp, Capsule;
LyN, Lymphatic nodule; Ly, Lymphocyte; k, higher magnification of IE. Bars=50 μm (a–i), 10 μm (insets of b, c), 2 μm (j, k).Lymph Nodes with In Vivo Cryotechnique 87
sides of inner endothelial cells. However, they were not seen
in outer endothelial cells (arrowheads, Fig. 5j). In the con-
nective tissues of capsules, they were seen in some cells
other than endothelial cells (white arrows, Fig. 5j).
Immunolocalization of type IV collagen or smooth muscle 
actin with LYVE-1 immunopositive endothelial cells
Finally, immunofluorescence labeling of LYVE-1 was
performed in mesenteric lymph nodes in cryosections pre-
pared with IVCT-FS (Fig. 6). After triple-immunostaining
for LYVE-1, type IV collagen and smooth muscle (Sm)-
actin, LYVE-1 was immunolocalized in the inner endo-
thelial cells and reticular cells of the subcapsular sinuses,
but not in outer endothelial cells, which were surrounded
by type IV collagen and Sm-actin (Fig. 6a–d). Thus, the
LYVE-1 immunolocalization was reconfirmed in the inner
endothelial cells of the subcapsular sinuses.
IV. Discussion
Subcapsular sinuses of lymph nodes have been thought
to play some important roles for filtering lymph fluid to
transport and process invading antigens into their parenchy-
ma, as well as both adhesion and migration of immune cells
and also metastatic cancer cells. The present study demon-
strated histological features of living mouse mesenteric
lymph nodes with IVCT, such as widely open lymphatic
sinuses and original locations of flowing lymphocytes. It is
also interesting to note that many small lymphocytes were
attached to inner endothelial cells in subcapsular sinuses, as
shown in Figures 2b and 5a. Thus, as the wide lumen of
lymphatic sinuses and flowing lymphocytes were main-
tained by using IVCT, it may reflect the natural subcapsular
sinuses of functional lymph nodes. Round fenestrations of
endothelial cells were demonstrated at the parenchymal
sides of the subcapsular sinus walls [35, 42, 43], indicating
that the inner endothelial cells are used as a route for anti-
gens and/or free cells to pass from the lymphatic sinuses to
the parenchyma of lymph nodes. As IVCT has been used to
avoid various technical artifacts, such as shrinkage and dis-
tortion always caused by conventional preparation methods
[1, 4, 14, 15, 16, 21, 31, 48], other dynamic experiments
with fluorescent-marker injection are also under consider-
ation [37].
The LYVE-1 was immunolocalized in the inner endo-
thelial cells and reticular cells of subcapsular sinuses, but
not in outer ones or in afferent lymphatic vessels, as shown
in Figures 3–6. Immunoelectron microscopy also showed
LYVE-1 in both luminal and basal cell membrane surfaces
of inner endothelial cells, but immunoreactivity of LYVE-1
was strongly observed in the luminal sides than that of
inner sides, as shown in Figure 5. The immunolocalization
Fig. 6. Immunofluorescence labeling of
LYVE-1 in cryosections of a mesen-
teric lymph node prepared by IVCT-
FS. Triple-immunoflurescence staining
for LYVE-1 (green in a, d), type IV
collagen α2 chain (Collagen IV; red in
b, d), and smooth muscle actin (Sm-
actin; blue in c, d). Intensity of type IV
collagen (white arrowheads in b, d) and
Sm-actin (black arrowheads in c, d)
immunoreactivities is relatively strong
along outer sides of SS. LYVE-1-
immunopositive cells are observed in
the capsular stroma (black arrows in a–
d). The LYVE-1 is immunolocalized in
inner endothelial cells along SS and
reticular cells (white arrows in a–d),
where type IV collagen or Sm-actin is
faintly immunostained. Bars=20 μm
(a–d).Bai et al. 88
of LYVE-1 was first identified as a lymph-specific receptor
for hyaluronic acid (HA) [2]. In addition, rather than facili-
tating degradation of HA, it was thought to be involved in
HA transportation across lymphatic endothelial cells, spe-
cifically movement of accumulated HA from lymphatic
sinuses to the lymph node parenchyma [29]. The possible
roles of the lymphatic endothelial cells in HA homeostasis
are also modified with HA binding by sialylation and self-
association [10, 17]. In addition, it was already shown that
injected fluorophore-conjugated HA was taken through the
endothelial cells of subcapsular sinuses [33]. The flow of
lymphatic fluid was examined by injection of fluorophore-
conjugated gelatin into the peritoneal cavity [24], showing
its movement through endothelial cells to medullary laby-
rinths. But in the previous studies by using injection of
soluble substances with different molecular weights, the
lymphatic parenchyma was impenetrable to those molecules
with about 70 kD [7]. The IVCT could be used to keep the
morphology in situ of lymph nodes, and dynamic experi-
ments with fluorescence-labeled tracers will be possible to
clarify it.
Our findings that the LYVE-1 was present at both
luminal and basal surfaces of inner endothelial cells, and
that the immunolocalization of LYVE-1 is more strongly
observed in the apical sides of inner endothelial cells, as
shown in Figure 5, are well compatible with this functional
concept. As schematically summarized as a model in
Figure 7, LYVE-1 immunolocalization is different between
inner and outer endothelial cells of subcapsular sinuses,
probably reflecting the different functions for the trans-
portation of HA and also the adhesion or migration of
CD44-positive lymphocytes [8–10]. Such different features
between inner and outer endothelial cells were already
reported by another histochemical approach for hydrolytic
enzymes [6].
Furthermore, as shown in Figure 6, LYVE-1 was not
expressed in outer endothelial cells contacting with type IV
collagen and/or smooth muscle cells. This finding is also
consistent with a study of developing lymph vessels, in
which mature lymphatic vessels surrounded by smooth
muscle cells usually reduced the LYVE-1 expression [36].
Finally, as shown in Figures 3, 4 and 5, the LYVE-1 was
immunolocalized in some cells of the capsules. As it was
already reported to be expressed in some types of macro-
phages [5, 32, 47] and other cells [11, 12], identification of
such cell types in the capsules will be another topic for
future studies.
In conclusion, functioning tissue structures of mesen-
teric lymph nodes of living mice, probably reflecting their
living states, were clearly described by the IVCT-FS
method, and their LYVE-1 immunolocalization in the sub-
capsular sinus was also visualized in the inner endothelial
cells, not in the outer ones, as summarized in Figure 7.
Fig. 7. Schematic representation of LYVE-1 immunolocalization in the subcapsular sinus (SS) of mouse mesenteric lymph nodes. LYVE-1
(pink) is localized in inner endothelial cells (IE) (yellow arrow) and reticulum cells of the SS or intermediate sinus (IS), but not in outer endo-
thelial cells (OE) (grey arrow) and endothelial cells for afferent lymphatic vessel (ALV). Many lymphocytes (green) are attached to the IE.
Matrices (red line) and smooth muscle cells (blue) in capsules (Cp) are organized under the basal side of the OE.Lymph Nodes with In Vivo Cryotechnique 89
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